News & Updates
Filter by Specialty:
Sleep irregularity measurement tied to hypertension, high BP
Hypertension and higher blood pressure (BP) levels are associated with the objective measurement of sleep irregularity, as assessed by standard deviation (SD) of sleep duration for 1 week, particularly in individuals without obstructive sleep apnoea (OSA), a study has shown.
Sleep irregularity measurement tied to hypertension, high BP
03 Apr 2023
Short nighttime sleepers at risk of long COVID, mental and CV diseases
Short nighttime sleepers are at higher risks of long COVID, depression and cardiovascular (CV) diseases than normal sleepers, according to three recent studies by researchers from the Chinese University of Hong Kong (CUHK).
Short nighttime sleepers at risk of long COVID, mental and CV diseases
03 Apr 2023
Long-term methylphenidate use does not stunt growth in children with ADHD
Long-term treatment with methylphenidate does not increase risks of growth impairment and psychiatric or neurological adverse events (AEs) in children and adolescents with attention deficit hyperactivity disorder (ADHD), according to the international ADDUCE study co-led by the University of Hong Kong (HKU) and the University of Melbourne.
Long-term methylphenidate use does not stunt growth in children with ADHD
03 Apr 2023
Tumour immune barrier determines immunotherapy efficacy in HCC
A tumour immune barrier (TIB) structure formed by the interaction of SPP1+ macrophages and cancer-associated fibroblasts (CAFs) appears to influence the efficacy of immunotherapy in patients with hepatocellular carcinoma (HCC), reveals a study.
Tumour immune barrier determines immunotherapy efficacy in HCC
01 Apr 2023
Secukinumab yields sustained positive effects on molecular, histopathologic psoriasis markers
Treatment with secukinumab leads to sustained clinical response among patients with psoriasis, with clinical response being associated with rapid and persistent normalization of keratin 16 (K16) and inflammatory gene expression for most patients, according to data from the ObePso-S study.
Secukinumab yields sustained positive effects on molecular, histopathologic psoriasis markers
01 Apr 2023
Long COVID: What are the risk and protective factors?
A population-based, multicentre study finds female gender, transportation-, logistics- or discipline-related occupation, living with domestic workers, smoking, poor or very poor self-perceived health status, ≥3 chronic diseases, chronic medication use, and critical severity of COVID-19 to be associated with severe long COVID, while prior receipt of ≥2 doses of COVID-19 vaccines serves as a protective factor.